Literature DB >> 7781136

Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event.

P Huang1, W Plunkett.   

Abstract

The nucleoside analogs fludarabine and gemcitabine inhibit cellular DNA synthesis by two different mechanisms: (1) direct termination of DNA strand elongation after the triphosphate of each drug is incorporation into DNA; and (2) indirect inhibition of DNA synthesis by decreasing cellular dNTPs through inhibition of ribonucleotide reductase. The present study demonstrated that incorporation of the analogs into DNA is critical for the cytotoxic action of these drugs in human T lymphoblastoid CEM cells. S phase cells, which actively incorporated the analogs into DNA, were most sensitive to the cytotoxic action of these compounds. A relatively short-term (5-24 h) cessation of cellular DNA synthesis without analog incorporation was not sufficient to cause cell death. The drug-treated cells died through apoptosis characterized by generation of internucleosomal DNA fragmentation and apoptotic morphology. Induction of high molecular mass (50-500 kb) DNA fragmentation was also observed in cells undergoing apoptosis; this type of DNA degradation was strongly correlated with the analog-induced cell death process. Inhibition of the analog incorporation into DNA by aphidicolin blocked both types of DNA fragmentation and apoptotic morphology, indicating the essential role of analog incorporation into DNA in drug-induced cell death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781136     DOI: 10.1007/BF00685844

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  36 in total

1.  Gene deletion, a mechanism of induced mutation by arabinosyl nucleosides.

Authors:  P Huang; M J Siciliano; W Plunkett
Journal:  Mutat Res       Date:  1989-02       Impact factor: 2.433

2.  Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes.

Authors:  K S Sellins; J J Cohen
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

3.  Detection of the initial stages of DNA fragmentation in apoptosis.

Authors:  P R Walker; L Kokileva; J LeBlanc; M Sikorska
Journal:  Biotechniques       Date:  1993-12       Impact factor: 1.993

4.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death.

Authors:  J J Cohen; R C Duke
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  Action of 2',2'-difluorodeoxycytidine on DNA synthesis.

Authors:  P Huang; S Chubb; L W Hertel; G B Grindey; W Plunkett
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

7.  Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes.

Authors:  D L Evans; C Dive
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

8.  Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine.

Authors:  H Gunji; S Kharbanda; D Kufe
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

Review 9.  Apoptosis in the genesis and prevention of cancer.

Authors:  H J Thompson; R Strange; P J Schedin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1992 Nov-Dec       Impact factor: 4.254

10.  Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia.

Authors:  S H Kaufmann; J E Karp; R J Jones; C B Miller; E Schneider; L A Zwelling; K Cowan; K Wendel; P J Burke
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

View more
  38 in total

Review 1.  Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.

Authors:  S Noble; K L Goa
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 2.  Apoptosis: molecular mechanisms and implications for cancer chemotherapy.

Authors:  H J Guchelaar; A Vermes; I Vermes; C Haanen
Journal:  Pharm World Sci       Date:  1997-06

3.  Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues.

Authors:  Nobuyuki Yoshio; Yasukazu Kawai; Hiroki Hori; Takanori Ueda
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

Review 4.  The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance.

Authors:  Deepa Sampath; William Plunkett
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075

5.  Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice.

Authors:  Brian R Thompson; Jian Shi; Hao-Jie Zhu; David E Smith
Journal:  Biochem Pharmacol       Date:  2020-06-27       Impact factor: 5.858

6.  Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

Authors:  Deepa Sampath; Jorge Cortes; Zeev Estrov; Min Du; Zheng Shi; Michael Andreeff; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

7.  Alteration of the carbohydrate for deoxyguanosine analogs markedly changes DNA replication fidelity, cell cycle progression and cytotoxicity.

Authors:  Jessica J O'Konek; Brendon Ladd; Sheryl A Flanagan; Mike M Im; Paul D Boucher; Tico S Thepsourinthone; John A Secrist; Donna S Shewach
Journal:  Mutat Res       Date:  2010-01-08       Impact factor: 2.433

8.  Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions.

Authors:  Roberto R Rosato; Jorge A Almenara; Sonia C Maggio; Stefanie Coe; Peter Atadja; Paul Dent; Steven Grant
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

Review 9.  Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review.

Authors:  Meredith A Morgan; Leslie A Parsels; Jonathan Maybaum; Theodore S Lawrence
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Fludarabine in the treatment of chronic lymphocytic leukemia: a review.

Authors:  Francesca Ricci; Alessandra Tedeschi; Enrica Morra; Marco Montillo
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.